TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)

TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts

Price target

53.350.000.00%
The 20 analysts offering 1 year price forecasts for 0M0F have a max estimate of — and a min estimate of —.

Analyst rating

Based on 23 analysts giving stock ratings to 0M0F in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0M0F EPS for the last quarter is −0.35 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.21 USD. Track more of TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) financials and stay on top of what is up with the company.
In the next quarter TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) revenue is expected to reach ‪249.81 M‬ USD. Check out TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) revenue and earnings and make informed decisions.
According to analysts, 0M0F price target is 53.35 USD with a max estimate of 75.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch TANDEM DIABETES CARE INC COM USD0.001(POST REV SPLT) stock price chart and keep track of the current situation with 0M0F news and stock market news.
We've gathered opinions of 23 analysts rating 0M0F stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.